-
公开(公告)号:US11753685B2
公开(公告)日:2023-09-12
申请号:US16953480
申请日:2020-11-20
Applicant: ILLUMINA, INC.
Inventor: Sarah E. Shultzaberger , Fiona Kaper , Sarah Kinnings , Suzanne Rohrback , Carlo Randise-Hinchliff
IPC: C12Q1/68 , C12P19/34 , C12Q1/6883 , C12N15/10
CPC classification number: C12Q1/6883 , C12N15/1096 , C12Q2600/118 , C12Q2600/158
Abstract: The present invention includes methods and materials for use in the detection preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the method including identifying in a biosample obtained from the pregnant women a plurality of circulating RNA (C-RNA) molecules.
-
公开(公告)号:US20230392207A1
公开(公告)日:2023-12-07
申请号:US18203734
申请日:2023-05-31
Applicant: ILLUMINA, INC.
Inventor: Sarah E. Shultzaberger , Suzanne Rohrback , Carlo Randise-Hinchliff
IPC: C12Q1/6883 , C12Q1/6806
CPC classification number: C12Q1/6883 , C12Q1/6806 , C12Q2600/158
Abstract: The present invention includes methods and materials for use in the detection preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the method including identifying in a biosample obtained from the pregnant women circulating RNA (C-RNA) molecules associated with preeclampsia.
-
公开(公告)号:US20210155987A1
公开(公告)日:2021-05-27
申请号:US16953480
申请日:2020-11-20
Applicant: ILLUMINA, INC.
Inventor: Sarah E. Shultzaberger , Fiona Kaper , Sarah Kinnings , Suzanne Rohrback , Carlo Randise-Hinchliff
IPC: C12Q1/6883 , C12N15/10
Abstract: The present invention includes methods and materials for use in the detection preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the method including identifying in a biosample obtained from the pregnant women a plurality of circulating RNA (C-RNA) molecules.
-
公开(公告)号:US20240127906A1
公开(公告)日:2024-04-18
申请号:US18484268
申请日:2023-10-10
Applicant: Illumina, Inc. , Illumina Cambridge Limited , Illumina Singapore PTE. LTD.
Inventor: Qi Wang , Suzanne Rohrback , Sarah Shultzaberger , Rebekah Karadeema , Leslie Beh Yee Ming , James Baye , Colin Brown
Abstract: This disclosure describes methods, non-transitory computer readable media, and systems that can use a computationally efficient model to determine a corrected methylation-level value for a specific sample nucleotide sequence. For instance, the disclosed systems determine a false positive rate and a false negative rate at which a given methylation sequencing assay converts cytosine bases. Based on the determined false positive rate and false negative rate, the disclosed systems determine a corrected methylation-level value that corrects for a bias of the given methylation sequencing assay.
-
5.
公开(公告)号:US20230313271A1
公开(公告)日:2023-10-05
申请号:US18172821
申请日:2023-02-22
Applicant: Illumina, Inc. , Illumina Cambridge Limited
Inventor: Steven Norberg , Luis Fernando Camarillo Guerrero , Colin Brown , Andrea Manzo , Sarah E. Shultzaberger , Michael Eberle , Sepideh Almasi , Suzanne Rohrback , Pascale Mathonet , Egor Dolzhenko
IPC: C12Q1/6809 , G16C20/70
CPC classification number: C12Q1/6809 , G16C20/70
Abstract: This disclosure describes methods, non-transitory computer readable media, and systems that can use a machine-learning to determine factors or scores indicating an error level with which a given methylation assay detects methylation of cytosine bases. For instance, the disclosed systems use a machine-learning model to generate a bias score indicating a degree to which a given methylation assay errs in detecting cytosine methylation when specific sequence contexts surround such cytosines compared to other sequence contexts. The machine-learning model may take various forms of models, including a decision-tree model, a neural network, or a combination of a decision-tree model and a neural network. In some cases, the disclosed system combines or uses bias scores from multiple machine-learning models to generate a consensus bias score.
-
公开(公告)号:US20230135486A1
公开(公告)日:2023-05-04
申请号:US18091186
申请日:2022-12-29
Applicant: ILLUMINA, INC.
Inventor: Sarah E. Shultzaberger , Fiona Kaper , Sarah Kinnings , Suzanne Rohrback , Carlo Randise-Hinchliff
IPC: C12Q1/6883 , C12N15/10
Abstract: The present invention includes methods and materials for use in the detection preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the method including identifying in a biosample obtained from the pregnant women a plurality of circulating RNA (C-RNA) molecules.
-
-
-
-
-